Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 7/20 | 0.48 |
| ▸ | OPRM1 | P35372 | 6/20 | 0.47 |
| ▸ | NPFFR1 | Q9GZQ6 | 2/20 | 0.47 |
| ▸ | NPFFR2 | Q9Y5X5 | 2/20 | 0.47 |
| ▸ | MC4R | P32245 | 1/20 | 0.47 |
| ▸ | NMUR2 | Q9GZQ4 | 5/20 | 0.46 |
| ▸ | NMUR1 | Q9HB89 | 5/20 | 0.46 |
| ▸ | EPHA2 | P29317 | 2/20 | 0.45 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31679321 | 0.93 | OPRM1 (0.52) | OPRD1OPRM1NPFFR1NPFFR2NMUR2 | |
| SCHEMBL31679458 | 0.91 | OPRD1 (0.52) | OPRD1OPRM1NPFFR1NPFFR2NMUR2 | |
| SCHEMBL31679389 | 0.90 | AGTR2 (0.50) | OPRD1OPRM1NMUR2NMUR1IL23R | |
| SCHEMBL31679343 | 0.89 | OPRM1 (0.54) | OPRD1OPRM1NPFFR1NPFFR2EPHA2 | |
| SCHEMBL31679349 | 0.89 | OPRD1 (0.51) | OPRD1OPRM1MC4RNMUR2NMUR1 | |
| SCHEMBL31679462 | 0.89 | AGTR2 (0.52) | OPRD1NMUR2NMUR1IL23R | |
| SCHEMBL31679413 | 0.87 | OPRM1 (0.53) | OPRD1OPRM1NPFFR1NPFFR2EPHA2 | |
| SCHEMBL31679316 | 0.87 | OPRM1 (0.53) | OPRD1OPRM1NPFFR1NPFFR2NMUR2 | |
| SCHEMBL31679374 | 0.87 | OPRM1 (0.48) | OPRD1OPRM1NPFFR1NPFFR2 | |
| SCHEMBL31679365 | 0.86 | OPRM1 (0.51) | OPRD1OPRM1NPFFR1NPFFR2NMUR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4610269-A1 | UROKINASE PLASMINOGEN ACTIVATOR SURFACE RECEPTOR (UPAR) LIGANDS FOR DIAGNOSTIC OR THERAPEUTIC USE | 3B Pharmaceuticals GmbH (DE) | 2025-09-03 | — | — | EP | disclosed |